InsiderTrades.com logo
Breaking Now: Biden's Disturbing Plan to "Reset" America
From Legacy Research   |   Ad
The “Great Reset” started on January 20th with the inauguration of Joe Biden. Between now and the midterms, the American economy could be reshaped forever – and renowned analyst Jeff Brown has found the “lynchpin” to the entire plan.
Go here before this message is removed.

BGNE Insider Trading (BeiGene)

Insider Ownership Percentage: 9.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $185,479,564.45

BeiGene Insider Trading History Chart

BeiGene Share Price & Price History

$308.27
▼ -6.35 (-2.02%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
Tiny Gold Firm Stuns Wall Street with High-Grade Gold Discovery
From Resource Stock Digest   |   Ad
Surrounded by the operations of NYSE-listed gold giants, see how this tiny exploration firm planted its flag in the sweet spot of an emerging gold area-play in Canada’s richest mineral belt. Trading below US$0.25 per share and hitting high-grade gold with each turn of the drill, what’s not to like?
Get the details here...
pixel

BeiGene Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/29/2021Jane HuangCMOSell1,500$324.00$486,000.00285,583  
1/29/2021Jane HuangCMOSell1,500$322.99$484,485.00285,583  
1/15/2021Howard LiangCFOSell12,600$344.90$4,345,740.001,573,715  
1/4/2021Bros. Advisors Lp BakerDirectorSell121,154$220.50$26,714,457.00  
12/29/2020Jane HuangCMOSell1,500$249.13$373,695.00285,583  
12/14/2020Howard LiangCFOSell91,900$229.04$21,048,776.001,573,715  
11/30/2020Jane HuangCMOSell1,500$267.82$401,730.00285,583  
10/29/2020Jane HuangCMOSell1,500$300.06$450,090.00285,583  
10/16/2020Xiaodong WangInsiderSell5,000$320.00$1,600,000.007,201,009  
10/5/2020Howard LiangCFOSell14,000$299.60$4,194,400.00168,415  
10/5/2020Xiaodong WangInsiderSell5,000$300.00$1,500,000.007,201,009  
9/29/2020Jane HuangCMOSell1,500$280.38$420,570.00285,583  
9/29/2020John OylerCEOSell54,303$280.39$15,226,018.178,927,570  
9/25/2020Xiaodong WangInsiderSell5,000$280.42$1,402,100.007,201,009  
9/17/2020Xiaodong WangInsiderSell5,000$260.27$1,301,350.007,201,009  
9/16/2020John OylerCEOSell27,275$254.77$6,948,851.759,633,509  
9/14/2020Howard LiangCFOSell14,000$250.27$3,503,780.00168,415  
9/14/2020John OylerCEOSell19,739$250.25$4,939,684.759,633,509  
9/3/2020Jane HuangCMOSell3,128$233.07$729,042.96285,583  
9/2/2020John OylerCEOSell61,042$233.21$14,235,604.8210,689,473  
8/31/2020John OylerCEOSell12,961$240.86$3,121,786.4610,689,473  
8/28/2020Jane HuangCMOSell3,000$242.21$726,630.00326,247  
8/21/2020John OylerCEOSell40,788$240.19$9,796,869.7211,483,019  
8/19/2020John OylerCEOSell29,866$234.56$7,005,368.9611,483,019  
8/14/2020John OylerCEOSell8,705$211.15$1,838,060.7512,681,320  
8/12/2020John OylerCEOSell19,820$212.10$4,203,822.0012,681,320  
8/11/2020Timothy Yung-Cheng ChenDirectorSell1,903$213.04$405,415.122,200  
8/10/2020Xiaodong WangInsiderSell4,000$211.06$844,240.007,201,009  
8/5/2020John OylerCEOSell17,254$223.27$3,852,300.5813,239,904  
8/3/2020John OylerCEOSell25,176$221.78$5,583,533.2813,464,206  
7/29/2020Jane HuangCMOSell3,000$209.93$629,790.00326,247  
7/22/2020John OylerCEOSell27,748$238.34$6,613,458.3213,991,473  
7/20/2020John OylerCEOSell28,762$251.85$7,243,709.7014,352,197  
7/20/2020Xiaobin WuInsiderSell3,300$249.22$822,426.001,423,562  
7/17/2020Xiaobin WuInsiderSell700$245.74$172,018.001,423,562  
7/15/2020Xiaobin WuInsiderSell2,700$241.11$650,997.001,466,462  
7/13/2020Xiaobin WuInsiderSell3,000$220.00$660,000.001,466,462  
7/8/2020John OylerCEOSell17,529$201.39$3,530,165.3115,069,472  
7/7/2020Jane HuangCMOSell3,921$200.00$784,200.00326,247  
7/7/2020Xiaodong WangInsiderSell6,000$200.00$1,200,000.007,267,569  
7/6/2020John OylerCEOSell17,362$197.11$3,422,223.8215,069,472  
7/1/2020John OylerCEOSell3,816$191.57$731,031.1215,770,354  
6/29/2020Howard LiangCFOSell300$191.23$57,369.00168,415  
6/29/2020Jane HuangCMOSell1,935$190.83$369,256.05326,247  
6/29/2020John OylerCEOSell1,435$192.60$276,381.0015,770,354  
6/26/2020Jane HuangCMOSell2,079$200.29$416,402.91326,247  
6/24/2020John OylerCEOSell14,381$187.34$2,694,136.5415,838,617  
6/22/2020John OylerCEOSell10,281$182.43$1,875,562.8315,838,617  
6/22/2020Xiaodong WangInsiderSell5,000$181.33$906,650.007,330,580  
6/8/2020Howard LiangCFOSell453$170.84$77,390.52116,428  
6/8/2020Jane HuangCMOSell631$170.84$107,800.04283,464  
6/8/2020Xiaobin WuInsiderSell2,800$170.83$478,324.001,380,415  
5/29/2020Jane HuangCMOSell1,500$163.86$245,790.00291,667  
5/19/2020Donald W GlazerDirectorSell10,000$169.84$1,698,400.003,497,678  
5/1/2020John OylerCEOSell4,635$141.43$655,528.0516,366,833  
5/1/2020Xiaobin WuInsiderSell7,024$141.33$992,701.92  
4/29/2020Jane HuangCMOSell1,500$162.30$243,450.00291,667  
4/16/2020Jane HuangCMOSell1,500$160.00$240,000.00291,667  
3/4/2020Xiaodong WangInsiderSell5,000$157.14$785,700.007,395,580  
1/21/2020Jane HuangCMOSell1,500$170.69$256,035.00291,667  
12/17/2019John OylerCEOSell62,259$160.62$10,000,040.5816,411,788  
12/16/2019Jane HuangCMOSell1,500$165.14$247,710.00291,667  
11/18/2019Howard LiangCFOSell25,000$194.34$4,858,500.00122,317  
11/18/2019Jane HuangCMOSell1,500$194.49$291,735.00291,667  
11/14/2019Xiaodong WangInsiderSell8,504$193.31$1,643,908.247,460,580  
11/5/2019Timothy Yung-Cheng ChenDirectorSell3,800$189.15$718,770.004,000  
11/4/2019Jane HuangCMOSell32,900$190.46$6,266,134.00291,667  
11/4/2019Xiaodong WangInsiderSell1,000$190.00$190,000.007,585,628  
11/1/2019Xiaodong WangInsiderSell1,000$170.00$170,000.007,585,628  
9/3/2019Jane HuangCMOSell2,862$144.45$413,415.90291,667  
8/23/2019Timothy Yung-Cheng ChenDirectorSell8,614$144.96$1,248,685.44  
8/12/2019Jane HuangCMOSell2,500$134.74$336,850.00328,873  
7/29/2019Jane HuangCMOSell10,130$134.54$1,362,890.20328,873  
7/8/2019John OylerCEOSell3,106$126.87$394,058.2217,221,155  
7/1/2019Xiaodong WangInsiderSell4,847$126.46$612,951.627,611,628  
6/27/2019Howard LiangCFOSell5,876$9.47$55,645.72122,317  
6/27/2019Jane HuangCMOSell430$124.52$53,543.603  
5/21/2019Howard LiangCFOSell23,200$130.21$3,020,872.0052,338  
5/20/2019Jane HuangCMOSell300$130.12$39,036.00271,621  
5/13/2019Donald W GlazerDirectorSell15,027$125.11$1,880,027.973,911,518  
5/6/2019Howard LiangCFOSell1,800$130.01$234,018.0052,338  
5/1/2019John OylerCEOSell2,824$125.18$353,508.32  
5/1/2019Xiaobin WuInsiderSell5,955$124.52$741,516.60  
4/8/2019Jane HuangCMOSell14,130$142.77$2,017,340.10271,621  
3/14/2019Donald W GlazerDirectorSell14,973$136.10$2,037,825.304,106,869  
3/11/2019Jane HuangCMOSell2,636$130.28$343,418.08271,621  
3/7/2019Jane HuangCMOSell71$140.50$9,975.50271,621  
3/6/2019John OylerCEOSell25,499$151.73$3,868,963.2717,298,245  
3/4/2019John OylerCEOSell4,588$152.01$697,421.8817,298,245  
3/1/2019Xiaodong WangDirectorSell5,000$146.82$734,100.00  
12/18/2018Amy C PetersonCMOSell20,000$133.68$2,673,600.00194,569  
12/10/2018John OylerCEOSell4,138$135.78$561,857.6417,420,172  
12/3/2018Xiaodong WangDirectorSell5,000$152.41$762,050.002,329  
11/28/2018John OylerCEOSell29,195$143.66$4,194,153.7017,420,172  
11/26/2018Jane HuangCMOSell3,000$139.58$418,740.00271,621  
11/26/2018John OylerCEOSell9,078$139.06$1,262,386.6817,420,172  
11/19/2018Xiaodong WangDirectorSell5,000$124.30$621,500.003,900  
11/12/2018Amy C PetersonCMOSell40,000$120.20$4,808,000.00194,569  
11/8/2018Amy C PetersonCMOSell14,711$126.07$1,854,615.77194,569  
9/4/2018Jane HuangCMOSell2,911$174.60$508,260.60  
8/30/2018Donald W GlazerDirectorSell2,000$179.00$358,000.0014,384  
8/23/2018Amy C PetersonCMOSell5,769$169.12$975,653.284,661  
8/13/2018Xiaodong WangDirectorSell3,449$158.77$547,597.73  
8/2/2018Bros. Advisors Lp BakerDirectorBuy5,814,100$108.00$627,922,800.00  
7/16/2018John OylerCEOSell2,550$164.12$418,506.00  
See Full Table

SEC Filings (Institutional Ownership Changes) for BeiGene (NASDAQ:BGNE)

60.65% of BeiGene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BeiGene Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
3/12/2021DekaBank Deutsche Girozentrale27,199$6.76M0.0%-1.8%0.030%
3/8/2021Dimensional Fund Advisors LP23,237$5.99M0.0%+0.2%0.025%
3/1/2021UBS Asset Management Americas Inc.186,869$48.29M0.0%+43.8%0.204%
2/25/2021Dimensional Fund Advisors LP23,237$5.99M0.0%+0.2%0.025%
2/25/2021Hsbc Holdings PLC57,969$14.96M0.0%-87.8%0.063%
2/19/2021JPMorgan Chase & Co.154,298$39.87M0.0%+186.3%0.169%
2/18/2021Old Well Partners LLC46,553$12.03M6.2%N/A0.051%
2/17/2021Voloridge Investment Management LLC27,205$7.03M0.1%N/A0.030%
2/17/2021United Capital Financial Advisers LLC2,651$0.69M0.0%N/A0.003%
2/17/2021Canada Pension Plan Investment Board146,325$37.81M0.1%+888.7%0.160%
2/16/2021Sands Capital Management LLC327,471$84.62M0.2%-29.8%0.359%
2/16/2021Morgan Stanley59,045$15.26M0.0%-8.8%0.065%
2/16/2021Baker BROS. Advisors LP11,668,897$3.02B11.4%-12.3%12.796%
2/16/2021Nuveen Asset Management LLC51,502$13.31M0.0%-12.4%0.056%
2/16/2021Guggenheim Capital LLC10,990$2.84M0.0%+67.0%0.012%
2/16/2021Price T Rowe Associates Inc. MD837,378$216.37M0.0%+6.5%0.918%
2/16/2021Amundi Pioneer Asset Management Inc.102,415$26.46M0.0%+358.2%0.112%
2/16/2021Capital International Ltd.52,166$13.48M0.8%-18.5%0.057%
2/16/2021Long Corridor Asset Management Ltd54,571$14.10M12.3%N/A0.060%
2/12/2021Stifel Financial Corp10,296$2.66M0.0%-7.7%0.011%
2/12/2021Caas Capital Management LP7,126$1.84M0.0%N/A0.008%
2/12/2021Caisse DE Depot ET Placement DU Quebec7,425$1.92M0.0%+222.8%0.008%
2/12/2021LPL Financial LLC1,054$0.27M0.0%+7.2%0.001%
2/12/2021The Manufacturers Life Insurance Company8,300$2.15M0.0%-44.6%0.009%
2/12/2021Montag A & Associates Inc.1,000$0.26M0.0%N/A0.001%
2/12/2021Credit Suisse AG115,778$29.92M0.0%+29.5%0.127%
2/12/2021Nomura Asset Management Co. Ltd.148,113$38.27M0.3%-5.8%0.162%
2/12/2021Virtus ETF Advisers LLC2,669$0.69M0.3%-25.1%0.003%
2/11/2021Krane Funds Advisors LLC20,713$5.35M0.2%N/A0.023%
2/11/2021Wetherby Asset Management Inc.1,211$0.31M0.0%+16.9%0.001%
2/11/2021Northern Trust Corp226,760$58.59M0.0%-31.1%0.249%
2/11/2021Baird Financial Group Inc.81,993$21.19M0.1%+2.6%0.090%
2/11/2021Public Employees Retirement Association of Colorado3,354$0.87M0.0%-72.6%0.004%
2/11/2021Barclays PLC76,117$19.67M0.0%+15.7%0.083%
2/11/2021Citigroup Inc.35,086$9.07M0.0%+95.5%0.038%
2/11/2021Handelsbanken Fonder AB15,600$4.03M0.0%+30.0%0.017%
2/11/2021Artal Group S.A.1,000,000$258.39M5.5%+11.1%1.097%
2/11/2021Teacher Retirement System of Texas6,009$1.55M0.0%-76.6%0.007%
2/11/2021Dai Ichi Life Insurance Company Ltd3,500$0.90M0.0%-29.9%0.004%
2/11/2021Skandinaviska Enskilda Banken AB publ6,600$1.71M0.0%+24.5%0.007%
2/11/2021Oppenheimer Asset Management Inc.13,380$3.46M0.1%+3.3%0.015%
2/11/2021Monashee Investment Management LLC18,600$4.81M0.6%N/A0.020%
2/11/2021Signaturefd LLC249$64K0.0%+90.1%0.000%
2/10/2021QS Investors LLC1,900$0.49M0.0%N/A0.002%
2/10/2021Baillie Gifford & Co.4,247,827$1.10B0.6%+196.0%4.658%
2/10/2021Aviva PLC14,730$3.81M0.0%-20.3%0.016%
2/10/2021Panagora Asset Management Inc.2,018$0.52M0.0%-73.2%0.002%
2/10/2021KBC Group NV6,754$1.75M0.0%+52.4%0.007%
2/10/2021Korea Investment CORP17,300$4.47M0.0%-51.3%0.019%
2/10/2021Mckinley Capital Management LLC Delaware25,756$6.66M0.5%-0.5%0.028%
2/10/2021Harvest Fund Management Co. Ltd29,828$7.71M0.7%+3.8%0.033%
2/9/2021Wells Fargo & Company MN63,442$16.39M0.0%-3.5%0.070%
2/9/2021Bessemer Group Inc.25,348$6.55M0.0%-35.5%0.028%
2/9/2021Fiera Capital Corp155,315$40.13M0.1%+0.4%0.170%
2/9/2021Seven Eight Capital LP2,100$0.54M0.1%N/A0.002%
2/9/2021Van ECK Associates Corp30,437$7.87M0.0%-79.8%0.033%
2/9/2021Bank of New York Mellon Corp57,963$14.98M0.0%-24.9%0.064%
2/9/2021Quantitative Systematic Strategies LLC2,322$0.60M0.1%-30.2%0.003%
2/9/2021Matthews International Capital Management LLC214,592$55.45M3.0%-0.5%0.235%
2/9/2021Blair William & Co. IL862$0.22M0.0%-4.8%0.001%
2/9/2021Mitsubishi UFJ Kokusai Asset Management Co. Ltd.9,606$2.48M0.0%+29.5%0.011%
2/9/2021ProShare Advisors LLC7,299$1.89M0.0%+3.5%0.008%
2/9/2021Profund Advisors LLC7,811$2.02M0.1%+52.1%0.009%
2/8/2021Vident Investment Advisory LLC9,552$2.47M0.1%-1.6%0.010%
2/8/2021Alliancebernstein L.P.808$0.21M0.0%-99.4%0.001%
2/8/2021Mondrian Capital Management LLC12,000$3.10M1.3%-27.3%0.013%
2/8/2021FDx Advisors Inc.2,819$0.73M0.0%+26.1%0.003%
2/8/2021New York State Common Retirement Fund37,475$9.68M0.0%-57.6%0.041%
2/8/2021BP PLC1,321$0.34M0.0%N/A0.001%
2/8/2021Sei Investments Co.14,201$3.67M0.0%-14.5%0.016%
2/8/2021Primecap Management Co. CA3,366,727$869.93M0.6%-0.2%3.692%
2/8/2021FMR LLC4,702,507$1.22B0.1%-7.4%5.157%
2/8/2021Russell Investments Group Ltd.3,922$1M0.0%+257.2%0.004%
2/6/2021Jennison Associates LLC7,391$1.91M0.0%+38.1%0.008%
2/5/2021Koshinski Asset Management Inc.9,779$0.31M0.0%N/A0.011%
2/5/2021BlackRock Inc.2,587,165$668.50M0.0%+15.2%2.837%
2/5/2021Aperio Group LLC25,462$6.58M0.0%+3.2%0.028%
2/5/2021Swiss National Bank109,856$28.39M0.0%-30.8%0.120%
2/5/2021University of Texas Texas AM Investment Managment Co.12,715$3.29M3.6%N/A0.014%
2/5/2021Sumitomo Mitsui Trust Holdings Inc.119,449$30.86M0.0%-52.5%0.131%
2/5/2021Vestmark Advisory Solutions Inc.781$0.20M0.0%+9.8%0.001%
2/5/2021SG Americas Securities LLC35,948$9.29M0.0%+375.3%0.039%
2/5/2021US Bancorp DE2,335$0.60M0.0%+2.2%0.003%
2/4/2021LVW Advisors LLC1,588$0.41M0.1%+28.4%0.002%
2/4/2021State of Wisconsin Investment Board13,272$3.43M0.0%-60.5%0.015%
2/3/2021State of New Jersey Common Pension Fund D18,176$4.70M0.0%-24.6%0.020%
2/2/2021M&G Investment Management Ltd.25,646$6.62M0.0%+11.4%0.028%
2/2/2021BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp19,400$5.01M0.0%+1,193.3%0.021%
2/2/2021First Trust Advisors LP6,386$1.65M0.0%+16.1%0.007%
2/2/2021Koshinski Asset Management Inc.9,779$0.31M0.1%N/A0.011%
2/2/2021Parallel Advisors LLC135$35K0.0%+35.0%0.000%
2/1/2021NN Investment Partners Holdings N.V.11,400$2.95M0.0%+67.6%0.013%
2/1/2021Victory Capital Management Inc.5,576$1.44M0.0%-52.5%0.006%
1/29/2021Fisher Asset Management LLC1,615$0.42M0.0%N/A0.002%
1/28/2021Fieldpoint Private Securities LLC503$0.13M0.0%N/A0.001%
1/28/2021Comerica Bank5,609$2.10M0.0%-3.4%0.006%
1/28/2021Zurcher Kantonalbank Zurich Cantonalbank11,937$3.08M0.0%-13.4%0.013%
1/28/2021Venturi Wealth Management LLC1,125$0.29M0.0%+21.4%0.001%
1/28/2021Dupont Capital Management Corp1,389$0.36M0.0%-66.3%0.002%
1/27/2021Segantii Capital Management Ltd6,531$1.72M0.1%N/A0.007%
Data available starting January 2016

See Full Table
BeiGene logo
BeiGene, Ltd., a commercial-stage biotechnology company, engages in discovering, developing, manufacturing, and commercializing medicines for cancer therapeutics in the People's Republic of China and the United States. Its commercial products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; ABRAXANE to treat breast cancer; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; Pamiparib for the treatment of various solid tumors; and BAT1706 to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC). The company's clinical stage drug candidates comprise Zanubrutinib, a BTK inhibitor to treat various lymphomas; Tislelizumab, an anti-PD-1 antibody to treat various solid and hematological cancers; Lifirafenib and BGB-3245 to treat various malignancies, such as melanoma, NSCLC, and endometrial cancer; and Sitravatinib, a multi-kinase inhibitor to treat NSCLC, melanoma, and other solid tumors. Its clinical stage drug candidates also include BGB-A333, a PD-L1 inhibitor to treat various solid tumors; Ociperlimab, a TIGIT inhibitor to treat various solid tumors; BGB-11417, a small molecule Bcl-2 inhibitor to treat mature B-cell malignancies; BGB-A445, an OX40 agonist antibody to treat solid tumors; Zanidatamab, a bispecific HER2 inhibitor to treat breast and gastric cancer; BGB-A425, a T-cell immunoglobulin and mucin-domain containing-3 inhibitor to treat various solid tumors; and BGB-15025, a small molecule inhibitor of HPK1. The company was incorporated in 2010 and is headquartered in Beijing, the People's Republic of China.
Read More

Today's Range

Now: $308.27
$302.97
$313.00

50 Day Range

MA: $326.86
$289.22
$355.96

52 Week Range

Now: $308.27
$136.48
$388.97

Volume

157,809 shs

Average Volume

314,904 shs

Market Capitalization

$28.23 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.91

Who are the company insiders with the largest holdings of BeiGene?

BeiGene's top insider investors include:
  1. John Oyler (CEO)
  2. Xiaodong Wang (Insider)
  3. Donald W Glazer (Director)
  4. Howard Liang (CFO)
  5. Xiaobin Wu (Insider)
  6. Jane Huang (CMO)
  7. Timothy Yung-Cheng Chen (Director)
  8. Bros Advisors Lp Baker (Director)
April 30th is approaching, are you prepared?
From True Market Insiders   |   Ad
A new president’s policies always influence key stocks.
Here’s where top billionaires are investing.
pixel